HOUSTON, Feb. 28 /PRNewswire/ -- US Oncology Holdings, Inc. ("Holdings" or the "Company"), the parent company of US Oncology, Inc. ("US Oncology"), one of the nation's largest cancer services companies, reported revenue of $771.6 million, EBITDA of $51.3 million, Adjusted EBITDA of $58.0 million, net loss of $14.8 million and operating cash flow of $74.2 million for the quarter ended December 31, 2007. For the year ended December 31, 2007, the Company reported revenue of $3.0 billion, EBITDA of $190.7 million, Adjusted EBITDA of $218.7 million, net loss of $35.0 million and operating cash flow of $164.7 million.
The results of Holdings include those of US Oncology, its wholly-owned
subsidiary, through which all operations are conducted. The results of
operations and financial position of Holdings are substantially identical
to those of US Oncology, with the exception of nominal administrative
expenses and items related to the capitalization of Holdings. For the
quarter ended December 31, 2007, US Oncology reported EBITDA of $51.2
million, Adjusted EBITDA of $58.0 million, net income of $0.3 million and
operating cash flow of $74.6 million. For the year ended December 31, 2007,
US Oncology reported EBITDA of $203.7 million, Adjusted EBITDA of $218.8
million, net income of $7.2 million and operating cash flow of $198.0
million. Differences between the results of Holdings and US Oncology, as
well as selected balance sheet data, are reconciled in this press release.
US Oncology Holdings Fourth Quarter and Fiscal Year Results
-- Adjusted EBITDA for the fourth quarter of 2007 was $58.0 million,
compared to $59.5 million for the fourth quarter of 2006 and
$50.5 million for the third quarter of 2007. Adjusted EBITDA for
fiscal 2007 was $218.7 million compared to $250.0 million in 2006.
-- In 2007, physicians affiliated under comprehensive service agreements
provided care to over 590,000 pati
|SOURCE US Oncology Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved